Soft, living materials made with algae glow under stress

Researchers have developed soft yet durable 3D-printed materials that glow in response to mechanical stress, such as compression, stretching or twisting. The materials derive their luminescence from single-celled algae known as dinoflagellates, which are embedded within the materials. The work was inspired by the bioluminescent waves caused by dinoflagellates during red tide events at San Diego’s beaches.

CU VET’s “3D Dog Eye Anatomy Model for Self Learning” Wins a Gold Medal at IWA 2020, Morocco

The 3D Dog Eye Anatomy Model for Self–learning, an innovation by the Faculty of Veterinary Science, Chulalongkorn University (CU VET) recently received the Gold Award at the International Innovation Week Africa (IWA) 2020 in Rabat, Morocco.

ORNL receives three 2021 FLC Awards for technology transfer

Three technologies developed by researchers at Oak Ridge National Laboratory have won National Technology Transfer Awards from the Federal Laboratory Consortium. The annual FLC Awards recognize significant accomplishments in transferring federal laboratory technologies to the marketplace.

Bristol innovation challenges regular touchscreens with new spray-on technique

A team at Bristol has challenged the idea that touchscreens are limited to 2D and rectangular shapes by developing an interactive display that can be sprayed in any shape.
Inspired by the way an artist creates graffiti on a wall and using a novel combination of sprayable electronics and 3D printing, the technique, called ProtoSpray, allows the creation of displays on surfaces that go beyond the usual rectangular and 2D shapes.

BIDMC physician-scientists spearhead effort to address nationwide COVID-19 testing swab shortage

As the numbers of patients with confirmed and suspected COVID-19 in the United States continue to rise exponentially, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, launched a collaborative and open-source effort to address the shortage of swabs that is hampering the nation’s ability to test for and track the spread of the virus. The team’s mission is to catalyze the development and clinical validation of novel designs for swabs for COVID-19 testing that can be manufactured quickly and in large numbers.